IA Clarington US Dividend Growth (CCM1302)
12.75
+0.08
(+0.66%)
CAD |
Mar 29 2023
Key Stats
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 2.00% | 70.09M | 0.00% | 41.45% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 41.72M | -2.16% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund’s objective is to achieve superior long-term capital appreciation consistent with the protection of the Fund’s capital. The Fund will invest primarily in a diversified portfolio of equity securities of large capitalization U.S. corporations, which, in the opinion of the portfolio manager, offer above average growth prospects. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | CCM1302 |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | US Equity |
| Category Index | Morningstar US Market GR CAD |
| Global Category Name | US Equity Large Cap Blend |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | IA Clarington Investments Inc |
| Prospectus Benchmark Index | |
| S&P 500 TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Donny Moss | 3.76 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
21
41.72M
-1.865B
Category Low
2.824B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of February 28, 2023
Risk
Performance Versus Category
As of March 29, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 29, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 4.59% | 284.05 | 1.26% |
| Apple Inc | 3.58% | 162.36 | 0.99% |
| MetLife Inc | 3.13% | 57.04 | 0.98% |
| Thermo Fisher Scientific Inc | 2.52% | 563.08 | 1.43% |
| UnitedHealth Group Inc | 2.47% | 469.96 | 0.72% |
| Johnson & Johnson | 2.38% | 153.44 | 0.08% |
| Progressive Corp | 2.33% | 143.75 | -0.51% |
| McDonald's Corp | 2.31% | 277.82 | 0.14% |
| CVS Health Corp | 2.13% | 74.67 | 0.78% |
| Bristol-Myers Squibb Co | 2.11% | 68.21 | 0.04% |
Basic Info
| Investment Strategy | |
| The Fund’s objective is to achieve superior long-term capital appreciation consistent with the protection of the Fund’s capital. The Fund will invest primarily in a diversified portfolio of equity securities of large capitalization U.S. corporations, which, in the opinion of the portfolio manager, offer above average growth prospects. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | CCM1302 |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | US Equity |
| Category Index | Morningstar US Market GR CAD |
| Global Category Name | US Equity Large Cap Blend |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | IA Clarington Investments Inc |
| Prospectus Benchmark Index | |
| S&P 500 TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Donny Moss | 3.76 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (3-29-23) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield (12-30-21) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 20.27 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of January 31, 2023
Fund Details
| Key Dates | |
| Inception Date | 1/4/2000 |
| Last Annual Report Date | 3/31/2022 |
| Last Prospectus Date | -- |
| Share Classes | |
| CCM1304 | Institutional |
| CCM1402 | Fee-based Advice |
| CCM1505 | Commission-based Advice |
| CCM1525 | Commission-based Advice |
| CCM1531 | Commission-based Advice |
| CCM1532 | Commission-based Advice |
| CCM1535 | Fee-based Advice |
| CCM3262 | -- |
| CCM3265 | -- |
| CCM3267 | -- |
| CCM3268 | -- |
| CCM3270 | -- |
| CCM3271 | -- |
| CCM3273 | -- |
| CCM9736 | Commission-based Advice |
| CCM9737 | Commission-based Advice |
| CCM9739 | Fee-based Advice |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |